NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
| CMPX_old | Compass Therapeutics Inc. | Other | Other | 2.53% |
| VOR | Vor Biopharma Inc | Healthcare | Biotechnology | 2.33% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.30% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.08% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.95% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.93% |
| PGEN | Precigen Inc | Healthcare | Biotechnology | 1.92% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| GLUE | Monte Rosa Therapeutics Inc | Healthcare | Biotechnology | 1.77% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.73% |
| REPL | Replimune Group Inc | Healthcare | Biotechnology | 1.71% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 1.70% |
| GNLX | Genelux Corporation Common Stock | Healthcare | Biotechnology | 1.69% |
| XNCR | Xencor Inc | Healthcare | Biotechnology | 1.64% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 1.63% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 1.58% |
| KPTI | Karyopharm Therapeutics Inc | Healthcare | Biotechnology | 1.58% |